Shuttle Pharmaceuticals Holdings (SHPH) Interest Expenses (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Interest Expenses of $300000.0 for Q1 2026, up 50.0% year-over-year from $200000.0 in Q1 2025, and up 140.0% quarter-over-quarter from $124998.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Interest Expenses (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Interest Expenses history runs 6 years deep, the most recent figure standing at $300000.0 for Q1 2026.
- In Q1 2026, Interest Expenses rose 50.0% year-over-year to $300000.0; the TTM figure through Mar 2026 stood at $724998.0 (up 420.17% YoY), while the FY2025 annual figure was $7.8 million, up 54.01% from the prior year.
- Interest Expenses for Q1 2026 stood at $300000.0, up from $124998.0 in the prior quarter.
- The five-year high for Interest Expenses was $623465.0 in Q3 2023, with the low at -$691308.0 in Q4 2024.
- The 5-year median for Interest Expenses is $200000.0 (2024), against an average of $227455.9.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses surged 3640.72% in 2023, then sank 226.18% in 2024.
- Shuttle Pharmaceuticals Holdings' Interest Expenses stood at $21712.0 in 2022, then soared by 2423.27% to $547853.0 in 2023, then tumbled by 226.18% to -$691308.0 in 2024, then jumped by 118.08% to $124998.0 in 2025, then surged by 140.0% to $300000.0 in 2026.
- Business Quant data shows SHPH's Interest Expenses at $300000.0 in Q1 2026, $124998.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 12,122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 124,998.00 |
| Dec 31, 2025 | 124,998.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 312,998.00 |
| Jun 30, 2025 | 312,998.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | -691,308.00 |
| Dec 31, 2024 | -691,308.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 430,685.00 |
| Jun 30, 2024 | 430,685.00 |
| Mar 31, 2024 | 497,515.00 |
| Mar 31, 2024 | 497,515.00 |
| Dec 31, 2023 | 547,853.00 |
| Dec 31, 2023 | 547,853.00 |